3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
61
Breast
8
Gynecologic
7
Gastrointestinal
6
Dermatologic
6
Head & Neck
5
Sarcoma
3
Lymphoid
3
Genitourinary
3
CNS
3
Other solid neoplasm
2
Plasma cell
1
Other hematologic neoplasm
1
Other
1
NET
1
Myeloid
1
Endocrine
1
Conditions
Sarcoma
2
Neuroendocrine Tumors
2
Neoplasms
2
Carcinoma, Neuroendocrine
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Radiosurgery
4
Paclitaxel
4
atezolizumab
3
Nivolumab
3
selpercatinib
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Carboplatin
2
vandetanib
1
taxane
1
sargramostim
1
romidepsin
1
repotrectinib
1
pralsetinib
1
pentetreotide
1
niraparib
1
liposomal doxorubicin
1
dostarlimab
1
aldesleukin
1
Vinorelbine
1
Topotecan
1
Thalidomide
1
Temozolomide
1
Specimen Handling
1
Rose Bengal
1
Radiation
1
RRx-001
1
Quality of Life
1
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Drug Therapy
×
Endocrine
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled